Correlation Between Madrigal Pharmaceuticals and Axsome Therapeutics
Can any of the company-specific risk be diversified away by investing in both Madrigal Pharmaceuticals and Axsome Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Madrigal Pharmaceuticals and Axsome Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Madrigal Pharmaceuticals and Axsome Therapeutics, you can compare the effects of market volatilities on Madrigal Pharmaceuticals and Axsome Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Madrigal Pharmaceuticals with a short position of Axsome Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Madrigal Pharmaceuticals and Axsome Therapeutics.
Diversification Opportunities for Madrigal Pharmaceuticals and Axsome Therapeutics
0.18 | Correlation Coefficient |
Average diversification
The 3 months correlation between Madrigal and Axsome is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Madrigal Pharmaceuticals and Axsome Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Axsome Therapeutics and Madrigal Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Madrigal Pharmaceuticals are associated (or correlated) with Axsome Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Axsome Therapeutics has no effect on the direction of Madrigal Pharmaceuticals i.e., Madrigal Pharmaceuticals and Axsome Therapeutics go up and down completely randomly.
Pair Corralation between Madrigal Pharmaceuticals and Axsome Therapeutics
Given the investment horizon of 90 days Madrigal Pharmaceuticals is expected to generate 21.5 times less return on investment than Axsome Therapeutics. But when comparing it to its historical volatility, Madrigal Pharmaceuticals is 1.04 times less risky than Axsome Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Axsome Therapeutics is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 8,695 in Axsome Therapeutics on October 23, 2024 and sell it today you would earn a total of 499.00 from holding Axsome Therapeutics or generate 5.74% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 94.74% |
| Values | Daily Returns |
Madrigal Pharmaceuticals vs. Axsome Therapeutics
Performance |
| Timeline |
| Madrigal Pharmaceuticals |
| Axsome Therapeutics |
Madrigal Pharmaceuticals and Axsome Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Madrigal Pharmaceuticals and Axsome Therapeutics
The main advantage of trading using opposite Madrigal Pharmaceuticals and Axsome Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Madrigal Pharmaceuticals position performs unexpectedly, Axsome Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axsome Therapeutics will offset losses from the drop in Axsome Therapeutics' long position.| Madrigal Pharmaceuticals vs. TG Therapeutics | Madrigal Pharmaceuticals vs. Terns Pharmaceuticals | Madrigal Pharmaceuticals vs. Hepion Pharmaceuticals | Madrigal Pharmaceuticals vs. Viking Therapeutics |
| Axsome Therapeutics vs. Incyte | Axsome Therapeutics vs. Sarepta Therapeutics | Axsome Therapeutics vs. ACADIA Pharmaceuticals | Axsome Therapeutics vs. Viking Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |